Related Experiment Video

Updated: Sep 29, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Autocrine activation of adenosine A1 receptors blocks D1A but not D1B dopamine receptor desensitization

Stéphane Le Crom1, Delphine Prou, Philippe Vernier

  • 1Développement, Evolution, Plasticité du Système Nerveux -UPR 2197, Institut de Neurobiologie Alfred Fessard, CNRS, Gif-sur-Yvette, France.

Journal of Neurochemistry
|October 2, 2002
PubMed

Insights

Adenosine, acting via A1 receptors, prevents D1A dopamine receptor desensitization. This interaction differs between D1A and D1B dopamine receptor subtypes, impacting dopamine signaling.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Adenosine is a neuromodulator influencing dopamine system activity.
  • Dopamine receptors, particularly D1-like subtypes (D1A and D1B), are crucial for neurotransmission.
  • Receptor desensitization is a key mechanism regulating cellular responses to agonists.

Purpose of the Study:

  • To investigate the role of adenosine in the desensitization of D1 dopamine receptor subtypes.
  • To elucidate the specific adenosine receptor subtype involved in modulating D1 receptor desensitization.
  • To characterize the differential effects of adenosine on D1A and D1B dopamine receptor desensitization.

Main Methods:

  • Measurement of cAMP accumulation in transfected COS-7 and stably expressing Ltk cells.
  • Exposure to dopamine agonists and adenosine receptor modulators (agonists, antagonists, deaminase).
  • Assessment of D1A and D1B dopamine receptor desensitization kinetics.

Main Results:

  • Long-term dopamine agonist exposure desensitized D1B but not D1A receptors in standard culture medium.
  • Endogenous adenosine, acting via A1 receptors, prevented D1A receptor desensitization.
  • Blocking A1 receptors or removing adenosine restored D1A receptor desensitization; A1 activation blocked desensitization but simultaneous activation with D1A led to delayed desensitization.

Conclusions:

  • Tonic adenosine signaling through A1 receptors inhibits D1A dopamine receptor desensitization.
  • Functional interactions between A1 and D1A receptors are complex and depend on activation kinetics.
  • Adenosine differentially regulates the desensitization of D1A and D1B dopamine receptor subtypes.

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology07:25

Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology

Published on: March 27, 2018

Related Concept Videos

Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers01:22

Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers

α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...